Cross reactive cellular immune responses in chickens previously exposed to low pathogenic avian influenza by Kapczynski, Darrell R et al.
PROCEEDINGS Open Access
Cross reactive cellular immune responses in
chickens previously exposed to low pathogenic
avian influenza
Darrell R Kapczynski
1*, Karen Liljebjelke
1, Gururaj Kulkarni
2, Henry Hunt
2, Hai Jun Jiang
1, Daniel Petkov
1
From International Symposium on Animal Genomics for Animal Health (AGAH 2010)
Paris, France. 31 May – 2 June 2010
Abstract
Background: Avian influenza (AI) infection in poultry can result in high morbidity and mortality, and negatively
affect international trade. Because most AI vaccines used for poultry are inactivated, our knowledge of immunity
against AI is based largely on humoral immune responses. In fact, little is known about cellular immunity following
a primary AI infection in poultry, especially regarding cytotoxic T lymphocytes (CTL’s).
Methods: In these studies, major histocompatibility complex (MHC)-defined (B
2/B
2) chickens were infected with
low pathogenic AI (LPAI) H9N2 and clinical signs of disease were monitored over a two weeks period. Splenic
lymphocytes from infected and naïve birds were examined for cross reactivity against homologous and
heterologous (H7N2) LPAI by ex vivo stimulation. Cellular immunity was determined by cytotoxic lysis of B
2/B
2
infected lung target cells and proliferation of T cells following exposure to LPAI.
Results: Infection with H9N2 resulted in statistically significant weight loss compared to sham-infected birds.
Splenic lymphocytes derived from H9N2-infected birds displayed lysis of both homologous (H9N2) and
heterologous (H7N2) infected target cells, whereas lymphocytes obtained from sham-infected birds did not. T cell
proliferation was determined to be highest when exposed to the homologous virus.
Conclusions: Taken together these data extend the findings that cellular immunity, including CTL’s, is cross
reactive against heterologous isolates of AI and contribute to protection following infection.
Background
Cell-mediated immunity (CMI) is antigen specific
immunity mediated by T lymphocytes and has been
suggested to be an important factor to the develop-
ment of protection in chickens vaccinated against viral
diseases [1]. The subsets of T lymphocytes: CD4+
helper cells and CD8+ cytotoxic cells constitute the
principal cells of the CMI response. For influenza,
CD8+ CTL’s play a crucial role in controlling infec-
tious virus from the lungs of mice [2][3]. A number of
recent studies have provided evidence that CMI direc-
ted against viral epitopes conserved among influenza A
viruses, such as those within the nucleoprotein (NP)
and hemagglutinin (HA), may contribute to protection
against influenza [4][5]. In fact, influenza virus NP-spe-
cific CTL’s generated through vaccination or intro-
duced by adoptive transfer enhance viral clearance and
lead to recovery of the host and protection from death
[6]. The objectives of this study were to determine the
level of cross reactive CMI against homologous and
heterologous isolates of LPAI.
Methods
Birds
Two-day-of age chickens were received from the USDA-
ARS-Avian Disease Oncology Laboratory (East Lansing,
Michigan) containing the B
2/B
2 defined MHC allele
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Viruses
Low pathogenic AI viruses of H9N2 (A/Chicken/NJ/
12220/97) and H7N2 (A/Turkey/Virginia/4259/02) sub-
types were propagated in the allantoic cavities of 9-11
day of embryonation SPF chicken eggs. Viral titers were
determined as previously described [7].
H9N2 infection
Two-week-old chickens (6 per group) were inoculated
via the intranasal route with 10
7 EID50 of H9N2 AI
virus or sham inoculum in 0.2 ml volume (1/2 each
nare) at 2 weeks of age. Chicken were monitored daily
for clinical signs of disease and weight loss monitored at
2, 4 and 7 days post inoculation (p.i.) following H9N2
primary infection. Mean weight was compared by
ANOVA using the Tukey Test (SigmaStat).
CTL lysis of target cells
Splenic lymphocytes were harvested from B
2/B
2 infected
and control chickens, three each, at 10 days post- infec-
tion as previously described [8]. MHC-matched lung
cells were obtained as previously described and used as
target cells for CTL assay [9]. Lung cells were infected
with either H9N2 or H7N2 AI at an MOI of 2 for 16
hours prior to testing. CTL activity was monitored using
the CytoTox96 nonradioactive assay (Promega) with the
% cells lysed determined by detection of cytosolic lactate
dehydrogenase in supernatants from control and
infected target cells.
Proliferation
Lymphocyte proliferation as a measure of cellular mem-
ory was performed with almarBlue™ (Invitrogen) as
previously described, using BPL-inactivated H9N2 (5 µg/
ml) or H7N2 (5 µg/ml) [8]. The T cell mitogen, conca-
navalin A (5 µg/ml), was used as a positive control.
Results
Weight loss following H9N2 infection
Infection with A\Chicken\NJ\97 (H9N2) following a nat-
ural route of exposure (intranasal) significantly
decreased weight gains at day 2, 4 and 7 post-inocula-
tion compared to control (uninfected) chickens (Fig 1).
In general, H9N2 infected birds weighed approximately
10% less than the sham inoculated group at each time
point. Apart from weight loss, overt signs of clinical dis-
ease or respiratory distress were not observed in the
H9N2 challenged group throughout the course of the
study.
Lysis of homologous and heterologous infected B
2/B
2
lung cells
Splenic T cells from inbred chickens infected with H9N2
AI lysed target cells infected with either homologous or
H7N2 AI at all effector:target (E:T) ratios tested (Fig 2). A
dose response based on E:T ratios was observed. At E:T
ratio of 40:1, 52 % of H9N2-infected B
2/B
2 lung target
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Figure 1 Effect of A/chicken/NJ/97 (H9N2) infection on weight
gain in MHC-defined (B
2/B
2) chickens at 2, 4 and 7 days post
infection. Two-week old birds received either PBS (Sham) or 10
7
EID50 H9N2 per bird via intranasal route. Bird weight was
significantly reduced between the two groups on each day tested
(p<0.05).
Figure 2 Recognition of homologous and heterologous LPAI ex
vivo by splenocytes derived from H9N2-infected chickens. The
cross-reactivity of lymphocytes was tested with MHC- matched B2/
B2 lung cell cultures infected with H9N2 or H7N2 LPAI. Effector:
target (E:T) ratios were 10, 20 and 40 for all subjects. Standard
deviation of the means was <10%. Spontaneous lysis from
splenocytes derived from naive birds were <7 % against either virus
(data not shown).
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were lysed. At lower E:T ratios, approximately 18 % (20:1)
and 10 % (10:1) of infected target cells were lysed in either
H9N2 or H7N2-infected lung cells. The splenic T cells
from H9N2 infected birds did not lyse uninfected target
cells, although spontaneous lysis was approximately 7 %
(data not shown). In addition, lymphocytes obtained from
sham-infected birds did not lyse infected or control lung
cell cultures (data not shown).
Proliferation
Splenocytes from H9N2 infected birds were tested for
CMI memory response against homologous and hetero-
logous AI via lymphocyte proliferative. The results (Fig.
3) indicate an increased proliferation response, as deter-
mined as an increase in the percent of alamaBlue™
reduced by the lymphocytes, against both the H9N2 and
H7N2 virus. The highest proliferative response was
against the homologous virus (42%), which was less than
the response to the T-cell mitogen, concanavalin A
(ConA). The T cell proliferative response to the hetero-
logous virus was approximately half (25%) of that
observed against the homologous virus.
Discussion
The main objective of the present research was to exam-
ine CMI following infection with low pathogenic AI, and
to identify cross reactive T cell immunity in chickens.
Using birds with a genetically defined MHC haplotype
(B
2/B
2), we found CTL’s isolated from H9N2 infected
b i r d sw e r ea c t i v ea g a i n s th o mologous and heterologous
isolates of AI based on lysis of MHC-matched target
cells and T cell proliferation. In addition, memory T
cells demonstrated proliferation in the presence of either
isolate tested. These data suggest that antigenic peptides
found in both isolates are presented by MHC-class I
and II molecules that lead to production of memory
CTL’s and stimulated proliferation of T cells, respec-
tively. The proteins containing these peptides remain to
be determined, although at least one report has identi-
fied a T cell epitope on the HA protein which could
activate both chicken CD4
+ and CD8
+ cells [4].
For this study birds infected with a LPAI H9N2 isolate
were the source of lymphocytes and examining cross
reactivity against a heterologous H7N2 isolate. We pro-
vide evidence that the H9N2 AI virus can induce cross
reactive CMI against the H7N2 AI isolate. Because the
majority of vaccines used across the world to protect
poultry from AI are inactivated, they must be matched
to the field subtype. While these vaccines induce protec-
tive antibodies against homologous subtypes based on
HA, little to no protective cross reactivity is afforded
against heterologous isolates [10]. In contrast, Seo et al.
was able to adaptively transfer CD8
+ lymphocytes from
H9N2-infected chickens and demonstrate protection
from H5N1 lethal challenge [9]. Whether the cross reac-
tive CMI demonstrated here could protect against a
H7N2 challenge in vivo, remains to be determined.
Conclusions
Taken together these data extend the findings that CMI,
including production of CTL’s, is cross reactive against
heterologous isolates of AI infection, and contribute to
protection following infection.
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